---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-007597"
form_type: "8-K"
ticker: "TERN"
cik: "0001831363"
company_name: "Terns Pharmaceuticals, Inc."
filed_at: "2023-03-13T23:59:59+00:00"
generated_at: "2026-06-18T04:49:42.010412+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "medium"
source: SEC EDGAR
---

# Terns Pharmaceuticals states no exposure to SVB failure; operations unaffected

## Summary
- Cash equivalents and marketable securities held at multiple large financial institutions.
- Cash balances in operating accounts also at multiple large banks, not concentrated at SVB.
- Company does not expect any disruptions to operations, including payroll, from recent bank closures.
- Forward-looking statements about sufficiency of cash resources.

## SEC filing metadata
- accession: 0000950170-23-007597
- form_type: 8-K
- ticker: TERN
- cik: 0001831363
- company_name: Terns Pharmaceuticals, Inc.
- filed_at: 2023-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: medium
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831363/000095017023007597/0000950170-23-007597-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831363/000095017023007597/tern-20230313.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-007597
- JSON: https://secwatch.observer/filing/0000950170-23-007597.json
- Plain text: https://secwatch.observer/filing/0000950170-23-007597.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.